Latest News

Latest News

Join The Future Of Life Sciences Media

 

In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.

 

 

Don’t wait for the media to pick up your story. Be the media.

Trending

[wtpsw_carousel design="design-14" show_date="false" show_author="false" show_comment_count="false" hide_empty_comment_count="true" slides_to_show="2" slides_to_scroll="2" autoplay_interval="4000" speed="1500" slider_height="400" limit="10"]

More News

Chinese Biotech Industry Shows No Signs of Slowing

Chinese Biotech Industry Shows No Signs of Slowing

Chinese biotech industry shows no signs of slowing as threat of U.S. restrictions loom The Chinese biotechnology sector continues to accelerate, signing high-value deals and expanding its global footprint even as the United States prepares new restrictions on...

read more
Navigating Life with Haemophilia with Pfizer

Navigating Life with Haemophilia with Pfizer

Life with haemophilia can be challenging but advances in science are helping people with haemophilia to lead active and fulfilling lives. What is Haemophilia? Haemophilia is a family of rare genetic blood disorders caused by a clotting factor deficiency, which...

read more
Chinese Biotech Industry Shows No Signs of Slowing

Chinese Biotech Industry Shows No Signs of Slowing

Chinese biotech industry shows no signs of slowing as threat of U.S. restrictions loom The Chinese biotechnology sector continues to accelerate, signing high-value deals and expanding its global footprint even as the United States prepares new restrictions on...

read more
Navigating Life with Haemophilia with Pfizer

Navigating Life with Haemophilia with Pfizer

Life with haemophilia can be challenging but advances in science are helping people with haemophilia to lead active and fulfilling lives. What is Haemophilia? Haemophilia is a family of rare genetic blood disorders caused by a clotting factor deficiency, which...

read more

Featured Articles

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Further News

7,000 Steps a Day May Improve Brain and Reduce Disease Risk

7,000 Steps a Day May Improve Brain and Reduce Disease Risk

Walking around 7,000 steps each day could help sharpen cognition and shield against a variety of chronic illnesses, according to a major new analysis. This target may be more attainable, yet still effective, than the widely publicised 10,000 step goal. Published in...

read more
US Scientists Create Human Embryos from Skin Cells

US Scientists Create Human Embryos from Skin Cells

In a ground breaking advance in reproductive biology, researchers in the United States have for the first time created early-stage human embryos by converting DNA from skin cells into functional eggs and then fertilising them with sperm. Though still at an...

read more

Further News

Astatine-211: The Alpha-Emitter Gaining Momentum in Targeted Radiotherapy

Astatine, the heaviest halogen and the rarest naturally occurring element, has long been a scientific curiosity. Among its many isotopes, ²¹¹At has emerged over the past decade as a frontrunner in the quest to harness alpha particles for highly targeted radiotherapy....

Blood Test for 50+ Cancers Shows Promise in Faster Diagnosis

A new multi cancer blood test developed by the United States biotechnology company Grail has demonstrated in North America the ability to detect a wide range of cancers, including many for which no screening programmes exist, at an early and potentially treatable...

Eli Lilly Expands U.S. Manufacturing with Multi-Billion Investment

Eli Lilly & Company is doubling down on U.S. investment, unveiling a series of ambitious plans to expand its domestic pharmaceutical manufacturing infrastructure. These efforts come amid mounting political pressure to reshore drug production and rising competition...

Trump’s Recent Guidance on Tylenol, Vaccines, and Children Draws Fire from Medical Community

In late September 2025, former U.S. President Donald J. Trump revived a series of controversial health claims and policy proposals concerning women especially pregnant women and children, triggering sharp pushback from medical experts, public health authorities, and...

7,000 Steps a Day May Improve Brain and Reduce Disease Risk

Walking around 7,000 steps each day could help sharpen cognition and shield against a variety of chronic illnesses, according to a major new analysis. This target may be more attainable, yet still effective, than the widely publicised 10,000 step goal. Published in...

US Scientists Create Human Embryos from Skin Cells

In a ground breaking advance in reproductive biology, researchers in the United States have for the first time created early-stage human embryos by converting DNA from skin cells into functional eggs and then fertilising them with sperm. Though still at an...

MHRA and NICE Pilot Aligned Pathway for Faster Patient Access

A Coordinated Effort to Accelerate Approvals The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a new initiative inviting early adopters to trial an accelerated and aligned...

Stem Cell Breakthrough: Woman Reverses Type 1 Diabetes Using Her Own Cells

In a pioneering medical achievement, a 25-year-old woman in China has become the first person in the world to reverse Type 1 diabetes using stem cells derived from her own body. The groundbreaking study, published in Cell in September 2024, marks a turning point in...

FDA Panel Rebuffs GSK’s Bid to Relaunch Blenrep Over Eye Toxicity Concerns

A panel of independent experts convened by the U.S. Food and Drug Administration (FDA) has recommended against approving GSK’s (GSK.L) blood cancer treatment Blenrep, citing concerns over known ocular side effects. The decision prompted a nearly 5% drop in the British...

NHS Leads Global Rollout of Groundbreaking ‘Trojan Horse’ Blood Cancer Treatment

The NHS in England is leading the world as the first healthcare system to introduce a pioneering ‘trojan horse’ therapy for patients with blood cancer, offering the potential to delay disease progression nearly three times longer than current treatment options....

FDA Picks George Tidmarsh as Head of Drug Regulation Division

The Food and Drug Administration commissioner, Marty Makary, has selected George Tidmarsh, a former biotech executive and Stanford-affiliated pediatrician, to lead the agency’s drug regulatory arm, according to a source familiar with the matter. The appointment of...

The Dawn of a New Era: World’s First mRNA Lung Cancer Vaccine Enters Global Clinical Trials

In a historic stride toward personalised cancer treatment, BioNTech—the German biotech giant behind one of the first COVID-19 mRNA vaccines—has launched the world’s first mRNA-based lung cancer vaccine, BNT116, into Phase I clinical trials across seven countries. This...

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.